These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38241595)

  • 1. CX3CR1 is a potential biomarker of immune microenvironment and prognosis in epithelial ovarian cancer.
    Shao D; Zhou H; Yu H; Zhu X
    Medicine (Baltimore); 2024 Jan; 103(3):e36891. PubMed ID: 38241595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
    Yue Y; Zhang Q; Sun Z
    Front Immunol; 2021; 12():758040. PubMed ID: 35140706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible factor-1α induces CX3CR1 expression and promotes the epithelial to mesenchymal transition (EMT) in ovarian cancer cells.
    Singh SK; Mishra MK; Singh R
    J Ovarian Res; 2019 May; 12(1):42. PubMed ID: 31077234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer.
    Xu H; Zou R; Li F; Liu J; Luan N; Wang S; Zhu L
    Cancer Med; 2021 Jun; 10(11):3655-3673. PubMed ID: 33934540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive Analysis of Prognostic Value of MEX3A and Its Relationship with Immune Infiltrates in Ovarian Cancer.
    Zhang P; Su T; Zhang S
    J Immunol Res; 2021; 2021():5574176. PubMed ID: 34189143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive and Prognostic Implications of Circulating CX3CR1
    Abdelfatah E; Long MD; Kajihara R; Oba T; Yamauchi T; Chen H; Sarkar J; Attwood K; Matsuzaki J; Segal BH; Dy GK; Ito F
    Cancer Res Commun; 2023 Mar; 3(3):510-520. PubMed ID: 37009132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of prostaglandin I2 synthase and its correlation with tumor-infiltrating immune cells in lung cancer, ovarian cancer, and gastric cancer.
    Dai D; Chen B; Feng Y; Wang W; Jiang Y; Huang H; Liu J
    Aging (Albany NY); 2020 May; 12(10):9658-9685. PubMed ID: 32463792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of CD47 and Its Association With Tumor Immune Microenvironment Heterogeneity in Ovarian Cancer.
    Yu L; Ding Y; Wan T; Deng T; Huang H; Liu J
    Front Immunol; 2021; 12():768115. PubMed ID: 34966389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD38 Predicts Favorable Prognosis by Enhancing Immune Infiltration and Antitumor Immunity in the Epithelial Ovarian Cancer Microenvironment.
    Zhu Y; Zhang Z; Jiang Z; Liu Y; Zhou J
    Front Genet; 2020; 11():369. PubMed ID: 32425977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and Function of Ligand CX3CL1 and its Receptor CX3CR1 in Cancer.
    Lu X
    Curr Med Chem; 2022; 29(41):6228-6246. PubMed ID: 35770395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins.
    Gou R; Zhu L; Zheng M; Guo Q; Hu Y; Li X; Liu J; Lin B
    J Transl Med; 2019 Sep; 17(1):275. PubMed ID: 31474227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial-mesenchymal transition interlinked with reprogrammed metabolism.
    Leung D; Price ZK; Lokman NA; Wang W; Goonetilleke L; Kadife E; Oehler MK; Ricciardelli C; Kannourakis G; Ahmed N
    J Transl Med; 2022 Dec; 20(1):556. PubMed ID: 36463238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High CX3CR1 expression predicts poor prognosis in paediatric acute myeloid leukaemia undergoing hyperleukocytosis.
    Mei N; Su H; Gong S; Du H; Zhang X; Wang L; Wang H
    Int J Lab Hematol; 2023 Feb; 45(1):53-63. PubMed ID: 36064206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers.
    Zhong L; Xie L; Yang Z; Li L; Song S; Cao D; Liu Y
    BMC Cancer; 2020 Aug; 20(1):766. PubMed ID: 32799825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylation model predicts prognosis of patients and affects immune microenvironment infiltration in epithelial ovarian carcinoma.
    Wang X; Li X; Wei L; Yu Y; Hazaisihan Y; Tao L; Jia W
    J Ovarian Res; 2024 Jul; 17(1):150. PubMed ID: 39030559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPP1 is a prognostic related biomarker and correlated with tumor-infiltrating immune cells in ovarian cancer.
    Gao W; Liu D; Sun H; Shao Z; Shi P; Li T; Yin S; Zhu T
    BMC Cancer; 2022 Dec; 22(1):1367. PubMed ID: 36585688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of CX3CL1/CX3CR1 axis predicts a poor prognosis of pancreatic ductal adenocarcinoma.
    Xu X; Wang Y; Chen J; Ma H; Shao Z; Chen H; Jin G
    J Gastrointest Surg; 2012 Aug; 16(8):1493-8. PubMed ID: 22639377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The miR-561-5p/CX
    Chen EB; Zhou ZJ; Xiao K; Zhu GQ; Yang Y; Wang B; Zhou SL; Chen Q; Yin D; Wang Z; Shi YH; Gao DM; Chen J; Zhao Y; Wu WZ; Fan J; Zhou J; Dai Z
    Theranostics; 2019; 9(16):4779-4794. PubMed ID: 31367257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRP12 is a prognostic biomarker and correlated with immune infiltrates in epithelial ovarian cancer.
    Ma R; Tang Z; Wang J
    J Gene Med; 2024 Jan; 26(1):e3585. PubMed ID: 37926491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.